ArticleMolecular and cellular endocrinology2018

Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.

Hillary Stires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.